Clinical risk factors of postoperative hyperkalemia after adrenalectomy in patients with aldosterone-producing adenoma

European Journal of Endocrinology
Kyeong Seon ParkSeong Yeon Kim

Abstract

Unilateral adrenalectomy is the first-line treatment for aldosterone-producing adenomas (APA). Hyperkalemia after adrenalectomy because of contralateral zona glomerulosa insufficiency has been reported. We investigated clinical risk factors to predict postoperative hyperkalemia in patients with APA undergoing adrenalectomy. This study was conducted by retrospectively reviewing medical records from 2000 to 2012 at Seoul National University Hospital and two other tertiary centers. Data from 124 patients who underwent adrenalectomy were included. Hyperkalemia was defined as serum potassium >5.5 mmol/l. Clinical preoperative risk factors included age, blood pressure, plasma renin activity (PRA), plasma aldosterone concentration (PAC), serum potassium, serum creatinine, glomerular filtration rate (GFR), the mass size on pathology, and mineralocorticoid receptor (MR) antagonist use. Out of 124 patients, 13 (10.5%) developed postoperative hyperkalemia. The incidences of transient and persistent hyperkalemia were 3.2 and 7.3% respectively. Preoperative PRA and PAC were not significantly different in postoperative hyperkalemic patients compared with normokalemic patients. Patients with persistent hyperkalemia were older, had a longer du...Continue Reading

References

Sep 1, 1975·The Journal of Clinical Endocrinology and Metabolism·E L BravoR C Tarazi
Jul 21, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M F GadallahF Boules
May 29, 1999·The Tohoku Journal of Experimental Medicine·R TaniguchiH Sasano
May 12, 2007·Clinical Endocrinology·William F Young
Jun 17, 2008·The Journal of Clinical Endocrinology and Metabolism·John W FunderUNKNOWN Endocrine Society
Jan 1, 2009·The Journal of Clinical Endocrinology and Metabolism·Martin ReinckeUNKNOWN Participants of German Conn's Registry
Jan 10, 2009·European Journal of Endocrinology·Gilberta GiacchettiMarco Boscaro
Mar 18, 2010·Nature Reviews. Nephrology·Marie Briet, Ernesto L Schiffrin
Dec 1, 2010·Best Practice & Research. Clinical Endocrinology & Metabolism·Marcus Quinkler, Paul M Stewart
Feb 25, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Vin-Cent WuUNKNOWN TAIPAI Study Group
Dec 14, 2011·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·V G FourkiotisM Quinkler
Feb 18, 2012·The Journal of Clinical Endocrinology and Metabolism·Takashi YonedaYoshiyu Takeda
Aug 16, 2012·The Journal of Clinical Endocrinology and Metabolism·Evelyn FischerMartin Reincke
Feb 14, 2013·Heart, Lung & Circulation·Michael Stowasser, Richard Douglas Gordon
Jun 4, 2013·Clinica Chimica Acta; International Journal of Clinical Chemistry·Wen-Fang ChiangShih-Hua Lin

❮ Previous
Next ❯

Citations

May 2, 2017·Endocrine Journal·Kyeong Seon ParkSeong Yeon Kim
Aug 14, 2018·The Journal of Clinical Endocrinology and Metabolism·Masao TakedaUNKNOWN JPAS Study Group
Oct 5, 2018·Journal of the Endocrine Society·Wasita WarachitSarat Sunthornyothin
Mar 17, 2020·Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences·Cristina PredaChristina M Ungureanu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.